American College Of Medical Toxicology, INC.
UEI SENNVSJDUES4 · AZ · SAM.gov record ↗
$2.4M
FY2025 obligations
5
Contract awards
Sep 16, 2019
First action
Jun 2, 2026
Latest action
Obligations by agency
- Department Of Health And Human Services$2.4M
Obligations by NAICS
Monthly obligations
May 25
Aug 25
Mar 26
May 26
Jun 26
Contracts ending within 18 months (recompete watch)
- 75D30123C16380 ↗$1.2M
TOXIC REGISTRY ACCESS
- Ends
- Jun 27, 2027
- Started
- Jul 6, 2023
- Agency
- Centers For Disease Control And Prevention
- NAICS
- 813920
- 75F40122F19001 ↗$312K
EXERCISING OY3 - TOXIC REGISTRY ONLINE ACCESS/COVID-19 TASK ORDER
- Ends
- Sep 28, 2027
- Started
- Sep 28, 2022
- Agency
- Food And Drug Administration
- NAICS
- 541690
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75D30123C16380 ↗ | TOXIC REGISTRY ACCESS | Centers For Disease Control And Prevention | 813920 | $1.2M | Jul 6, 2023 | Jun 27, 2027 |
| 75F40122F19001 ↗ | EXERCISING OY3 - TOXIC REGISTRY ONLINE ACCESS/COVID-19 TASK ORDER | Food And Drug Administration | 541690 | $312K | Sep 28, 2022 | Sep 28, 2027 |
Largest awards
- 75D30123C16380 ↗$1.2M
TOXIC REGISTRY ACCESS
- Ends
- Jun 27, 2027
- Started
- Jul 6, 2023
- Agency
- Centers For Disease Control And Prevention
- NAICS
- 813920
- 75F40123C00184 ↗$867K
CHARACTERIZE NALOXONES CLINICAL USE, RISKS, BENEFITS, AND EFFECTIVENESS FOR REVERSING OPIOID OVERDOSES IN PRE-HOSPITAL SETTINGS. USING QUALITATIVE AND QUANTITATIVE BLOOD TOXICOLOGY TESTS, DETERMINE THE RISKS, BENEFITS, EFFECTIVENESS OF HIGH DOSE NAL
- Ends
- Sep 28, 2026
- Started
- Sep 24, 2023
- Agency
- Food And Drug Administration
- NAICS
- 541990
- 75F40122F19001 ↗$312K
EXERCISING OY3 - TOXIC REGISTRY ONLINE ACCESS/COVID-19 TASK ORDER
- Ends
- Sep 28, 2027
- Started
- Sep 28, 2022
- Agency
- Food And Drug Administration
- NAICS
- 541690
- 75D30126P21010 ↗$65K
AGENTS OF OPPORTUNITY FOR TERRORISM
- Ends
- Nov 6, 2026
- Started
- May 11, 2026
- Agency
- Centers For Disease Control And Prevention
- NAICS
- 813920
TOXIC REGISTRY ACCESS
- Ends
- —
- Started
- Sep 16, 2019
- Agency
- Food And Drug Administration
- NAICS
- 541714
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75D30123C16380 ↗ | TOXIC REGISTRY ACCESS | Centers For Disease Control And Prevention | 813920 | $1.2M | Jul 6, 2023 | Jun 27, 2027 |
| 75F40123C00184 ↗ | CHARACTERIZE NALOXONES CLINICAL USE, RISKS, BENEFITS, AND EFFECTIVENESS FOR REVERSING OPIOID OVERDOSES IN PRE-HOSPITAL SETTINGS. USING QUALITATIVE AND QUANTITATIVE BLOOD TOXICOLOGY TESTS, DETERMINE THE RISKS, BENEFITS, EFFECTIVENESS OF HIGH DOSE NAL | Food And Drug Administration | 541990 | $867K | Sep 24, 2023 | Sep 28, 2026 |
| 75F40122F19001 ↗ | EXERCISING OY3 - TOXIC REGISTRY ONLINE ACCESS/COVID-19 TASK ORDER | Food And Drug Administration | 541690 | $312K | Sep 28, 2022 | Sep 28, 2027 |
| 75D30126P21010 ↗ | AGENTS OF OPPORTUNITY FOR TERRORISM | Centers For Disease Control And Prevention | 813920 | $65K | May 11, 2026 | Nov 6, 2026 |
| 75F40119D10031 ↗ | TOXIC REGISTRY ACCESS | Food And Drug Administration | 541714 | $0 | Sep 16, 2019 | — |